Chronic Rhinosinusitis With Nasal Polyps Clinical Trial
Official title:
Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)
Primary objective: to investigate the efficacy of Mepolizumab 100 milligram (mg) every month compared to placebo in reducing validated Sinonasal Outcome Test -22 score and on reducing endoscopic Nasal Polyp Score. The participants have a triad of chronic rhinosinusitis with nasal polyps (CRSwNP), asthma and non-steroidal anti-inflammatory drug exacerbated respiratory disease (NERD). The investigators will evaluate whether mepolizumab reduces the need for increased drug dosage (topical corticosteroid or bronchodilator dosage) and improves lung and nasal function more effectively than placebo. This first visit ensures the inclusion and exclusion criteria of the subject. If necessary, NERD will be verified by an ASA challenge test at a second additional visit. Participants have also 6 visits, on four of which subcutaneous injection of the study product is administered. During visits, a clinical examination, airway function tests, and nasal, blood, urine, and stool samples are also taken to elucidate predictive biomarkers of severely symptomatic NERD patients.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05895929 -
The Role of IL5 in Epithelial Cell Integrity
|
Early Phase 1 | |
Active, not recruiting |
NCT05891483 -
Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps
|
Phase 2 | |
Active, not recruiting |
NCT04998604 -
EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
|
Phase 4 | |
Recruiting |
NCT06069310 -
Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma
|
||
Recruiting |
NCT05009758 -
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
|
N/A | |
Active, not recruiting |
NCT05529784 -
Dupilumab in the Treatment of Severe Uncontrolled CRSwNP: a Multicentre Observational Real-life Study (DUPIREAL)
|
||
Recruiting |
NCT05902325 -
Identifying Predictors Of Response To Mepolizumab In CRSwNP
|
Phase 4 | |
Completed |
NCT05049122 -
Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)
|
Phase 4 | |
Not yet recruiting |
NCT05598411 -
CST1-Guided Oral Glucocorticoids Management for CRSwNP
|
Phase 4 | |
Active, not recruiting |
NCT05553951 -
Adherence in Global Airways
|
N/A | |
Recruiting |
NCT05131464 -
The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps
|
Phase 2 | |
Recruiting |
NCT05598424 -
CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps
|
Phase 4 | |
Active, not recruiting |
NCT05649813 -
A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region
|
||
Recruiting |
NCT04628442 -
Tissue Immune Interaction in Nasal Polyposis
|
||
Active, not recruiting |
NCT06118554 -
3D Printing to Improve Nasal Irrigation Outcome
|
N/A | |
Active, not recruiting |
NCT04596189 -
Dupilumab for Prevention of Recurrence of CRSwNP After ESS
|
Phase 4 | |
Recruiting |
NCT02668861 -
Effect of Oral Vitamin D3 on Chronic Rhinosinusitis Treatment in Adults With Lower Vitamin D Levels
|
Phase 3 | |
Active, not recruiting |
NCT05878093 -
Dupilumab in Chinese Adult Participants With CRSwNP
|
Phase 3 | |
Completed |
NCT05931744 -
The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05938972 -
Real Life Study of Biologicals in Patients With Severe CRSwNP
|